ThermoGenesis Holdings (THMO) Misses Q3 EPS by 27c, Revenues Miss

Go back to ThermoGenesis Holdings (THMO) Misses Q3 EPS by 27c, Revenues Miss

ThermoGenesis Holdings Announces Financial Results for the Third Quarter Ended September 30, 2020 and Provides Corporate Update

November 12, 2020 4:05 PM EST

RANCHO CORDOVA, Calif., Nov. 12, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced financial and operating results for the third quarter ended September 30, 2020 and provided a corporate update.

Financial Results for the Quarter Ended September 30, 2020

Net Revenues. Consolidated net revenues for the three months ended September 30, 2020 were $2.4 million compared to $4.1 million for the three months ended September 30, 2019, a decrease of $1.7 million or 42%. The decrease was driven by lower AXP®... More